0

    539730

    FREDUN

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    Fredun Pharmaceuticals Limited Share Price Today

    Investment Returns

    Over 1 Month 9.78% Over 3 Months 55.81% Over 6 Months 89.13% Over 1 Year 203.37%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    Fredun Pharmaceuticals Limited fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 1,518.10
    • P/E Ratio (TTM) 47.57
    • Beta 0.29
    • Book Value / share 163.14
    • Return on equity 15.81%
    • EPS (TTM) 20.08
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 11.07
    info icon alternate text

    Fredun Pharmaceuticals Limited Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 210.41
    Operating Expense 201.52
    Net Profit 11.07
    Net Profit Margin (%) 5.26
    Earnings Per Share (EPS) 20.22
    EBITDA 29.13
    Effective Tax Rate (%) 4.07
    Particulars DEC 2025 (Values in Cr)
    Revenue 159.93
    Operating Expense 146.92
    Net Profit 10.48
    Net Profit Margin (%) 6.55
    Earnings Per Share (EPS) 22.19
    EBITDA 26.33
    Effective Tax Rate (%) 25.14
    Particulars SEP 2025 (Values in Cr)
    Revenue 143.59
    Operating Expense 132.28
    Net Profit 9.73
    Net Profit Margin (%) 6.77
    Earnings Per Share (EPS) 20.61
    EBITDA 22.34
    Effective Tax Rate (%) 25.13
    Particulars JUN 2025 (Values in Cr)
    Revenue 119.40
    Operating Expense 110.81
    Net Profit 6.77
    Net Profit Margin (%) 5.67
    Earnings Per Share (EPS) 14.33
    EBITDA 16.99
    Effective Tax Rate (%) 25.11
    Particulars MAR 2025 (Values in Cr)
    Revenue 165.44
    Operating Expense 159.37
    Net Profit 7.07
    Net Profit Margin (%) 4.27
    Earnings Per Share (EPS) 14.98
    EBITDA 17.43
    Effective Tax Rate (%) 12.06
    Particulars MAR 2026 (Values in Cr)
    Revenue 633.33
    Operating Expense 591.54
    Net Profit 33.21
    Net Profit Margin (%) 5.24
    Earnings Per Share (EPS) 68.01
    EBITDA 94.78
    Effective Tax Rate (%) 30.22
    Particulars MAR 2025 (Values in Cr)
    Revenue 451.71
    Operating Expense 428.00
    Net Profit 20.81
    Net Profit Margin (%) 4.60
    Earnings Per Share (EPS) 44.83
    EBITDA 55.10
    Effective Tax Rate (%) 26.38
    Particulars MAR 2024 (Values in Cr)
    Revenue 346.58
    Operating Expense 327.62
    Net Profit 15.62
    Net Profit Margin (%) 4.50
    Earnings Per Share (EPS) 33.32
    EBITDA 38.90
    Effective Tax Rate (%) 27.17
    Particulars MAR 2023 (Values in Cr)
    Revenue 274.34
    Operating Expense 258.99
    Net Profit 10.81
    Net Profit Margin (%) 3.94
    Earnings Per Share (EPS) 22.93
    EBITDA 29.59
    Effective Tax Rate (%) 38.26
    Particulars MAR 2022 (Values in Cr)
    Revenue 221.74
    Operating Expense 217.48
    Net Profit 6.34
    Net Profit Margin (%) 2.85
    Earnings Per Share (EPS) 14.29
    EBITDA 15.43
    Effective Tax Rate (%) 26.27
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 482.77
    ROE % 15.55
    ROCE % 21.12
    Total Debt to Total Equity 0.93
    EBITDA Margin 14.88
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 299.43
    ROE % 13.96
    ROCE % 15.97
    Total Debt to Total Equity 1.18
    EBITDA Margin 12.10
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 483.87
    ROE % 15.81
    ROCE % 21.28
    Total Debt to Total Equity 0.92
    EBITDA Margin 14.92
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 299.47
    ROE % 15.83
    ROCE % 18.72
    Total Debt to Total Equity 1.03
    EBITDA Margin 12.14
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 255.15
    ROE % 14.34
    ROCE % 16.95
    Total Debt to Total Equity 0.88
    EBITDA Margin 11.17
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 194.27
    ROE % 13.15
    ROCE % 17.43
    Total Debt to Total Equity 0.85
    EBITDA Margin 10.78
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 153.07
    ROE % 11.41
    ROCE % 12.90
    Total Debt to Total Equity 0.83
    EBITDA Margin 6.91
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 64.98
    Total Assets 642.08
    Total Liabilities 642.08
    Total Equity 278.10
    Share Outstanding 0
    Price to Book Ratio 3.46
    Return on Assets (%) 5.08
    Return on Capital (%) 6.52
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 5.22
    Total Assets 487.41
    Total Liabilities 487.41
    Total Equity 141.38
    Share Outstanding 0
    Price to Book Ratio 2.23
    Return on Assets (%) 4.04
    Return on Capital (%) 6.4
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 64.95
    Total Assets 642.13
    Total Liabilities 642.13
    Total Equity 278.71
    Share Outstanding 0
    Price to Book Ratio 3.46
    Return on Assets (%) 5.17
    Return on Capital (%) 6.63
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.28
    Total Assets 486.65
    Total Liabilities 486.65
    Total Equity 141.40
    Share Outstanding 0
    Price to Book Ratio 2.23
    Return on Assets (%) 4.27
    Return on Capital (%) 6.76
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.35
    Total Assets 307.59
    Total Liabilities 307.59
    Total Equity 121.47
    Share Outstanding 0
    Price to Book Ratio 2.81
    Return on Assets (%) 5.07
    Return on Capital (%) 6.88
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.43
    Total Assets 257.27
    Total Liabilities 257.27
    Total Equity 96.37
    Share Outstanding 0
    Price to Book Ratio 4.00
    Return on Assets (%) 4.20
    Return on Capital (%) 5.91
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 2.07
    Total Assets 186.98
    Total Liabilities 186.98
    Total Equity 68.06
    Share Outstanding 0
    Price to Book Ratio 5.98
    Return on Assets (%) 3.38
    Return on Capital (%) 5.24
    Particulars MAR 2026 (Values in Cr)
    Net Income 32.62
    Cash from Operations 12.90
    Cash from Investing -73.59
    Cash from Financing 121.44
    Net change in Cash 59.75
    Free Cash Flow 86.50
    Particulars MAR 2025 (Values in Cr)
    Net Income 20.03
    Cash from Operations -16.59
    Cash from Investing -6.35
    Cash from Financing 26.65
    Net change in Cash 3.69
    Free Cash Flow -10.49
    Particulars MAR 2026 (Values in Cr)
    Net Income 33.20
    Cash from Operations 16.01
    Cash from Investing -73.58
    Cash from Financing 121.81
    Net change in Cash 64.67
    Free Cash Flow 89.59
    Particulars MAR 2025 (Values in Cr)
    Net Income 20.80
    Cash from Operations -22.44
    Cash from Investing -5.99
    Cash from Financing 25.90
    Net change in Cash -1.07
    Free Cash Flow -16.44
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.62
    Cash from Operations -0.43
    Cash from Investing -7.63
    Cash from Financing 5.99
    Net change in Cash -2.08
    Free Cash Flow 7.20
    Particulars MAR 2023 (Values in Cr)
    Net Income 10.75
    Cash from Operations -14.40
    Cash from Investing -9.40
    Cash from Financing 25.17
    Net change in Cash 1.36
    Free Cash Flow -4.91
    Particulars MAR 2022 (Values in Cr)
    Net Income 6.31
    Cash from Operations -2.38
    Cash from Investing -4.14
    Cash from Financing 7.46
    Net change in Cash 0.94
    Free Cash Flow 1.90
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 12.85 1.49 237.26 23.12 38.85
    BLISS GVS PHARMA LTD 482.50 38.79 4.28 5117.21 118.35 552.90
    CIPLA LTD 1418.40 30.10 3.32 114584.78 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 431.50 19.03 3.12 1269.95 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 30.96 21.65 3.98 237.26 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 537.90 24.11 4.20 1555.10 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8025.95 104.82 22.98 20064.88 7630.00 9850.00
    BLISS GVS PHARMA LTD 482.50 52.16 4.42 5117.21 118.35 552.90

    Fredun Pharmaceuticals Limited shareholding pattern

    Holding
    51.43%
    44.57%
    1.05%
    2.93%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    Fredun Pharmaceuticals Limited Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    917.95 -3.89 redarrow
    red-green-graph indicator
    4 Bearish
    12 Bullish
    • 5 Days 947.40
    • 26 Days 883.50
    • 10 Days 925.40
    • 50 Days 833.80
    • 12 Days 918.80
    • 100 Days 752.80
    • 20 Days 897.20
    • 200 Days 645.60
    979.27 PIVOT
    First Support 959.53 First Resistance 1013.53 Second Support 925.27 Second Resistance 1033.27 Third Support 905.53 Third Resistance 1067.53
    RSI 61.27 ADX 19.58 MACD 35.33 Williams % R -25.02 Commodity Channel Index (CCI) 123.21
    Date 2026-07-17 Week 11587.00 Same Day 8743.00 Month 8359.00
    1 Year 0.31 3 Year 0.56
    Over 1 Month
    9.78% down
    Over 1 Year
    203.37% down
    Over 3 Months
    55.81% down
    Over 3 Years
    53.09% down
    Over 6 Months
    89.13% down
    Over 5 Years
    47.67% down

    Fredun Pharmaceuticals Limited Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    23 Jun 2026 0.7 Final 23 Jun 2026 Equity shares
    23 Sep 2025 0.7 Final 23 Sep 2025 Equity shares
    23 Sep 2024 0.7 Final 23 Sep 2024 Equity shares
    22 Sep 2023 0.7 Final 22 Sep 2023 Equity shares
    16 Sep 2021 0.7 Final 18 Sep 2021 Equity shares
    16 Sep 2019 0.65 Final 18 Sep 2019 Equity shares
    18 Sep 2018 0.6 Final 21 Sep 2018 Equity shares
    20 Sep 2017 0.6 Final 22 Sep 2017 Equity shares
    11 Apr 2016 0.6 Interim 13 Apr 2016 Equity shares
    Ex-Date Ex-Bonus Ratio
    16 Jul 2026 16 Jul 2026 2:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Fredun Pharmaceuticals Ltd?

    Answer Field

    Fredun Pharmaceuticals Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 917.95 as on Jul 20 2026 10:13 AM.

    What is the Market Cap of Fredun Pharmaceuticals Ltd Share?

    Answer Field

    The market cap of Fredun Pharmaceuticals Ltd for NSE ₹ 0.00 & for BSE ₹ 1,518.10 as on Jul 20 2026 10:13 AM.

    What is the 52 Week High and Low of Fredun Pharmaceuticals Ltd?

    Answer Field

    The 52 Week High and Low of Fredun Pharmaceuticals Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 999.00 and ₹ 299.63.

    What is 1 year return for Fredun Pharmaceuticals Ltd?

    Answer Field

    The 1 year returns on the stock has been 203.37%.

    What is the P/E Ratio of Fredun Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 20 2026 10:13 AM the price-to-earnings (PE) ratio for Fredun Pharmaceuticals Ltd share is 47.57.

    What is the PB ratio of Fredun Pharmaceuticals Ltd Share?

    Answer Field

    As on Jul 20 2026 10:13 AM, the price-to-book (PB) ratio for Fredun Pharmaceuticals Ltd share is 163.14.

    How to Buy Fredun Pharmaceuticals Ltd Share?

    Answer Field

    You can trade in Fredun Pharmaceuticals Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Fredun Pharmaceuticals Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Fredun Pharmaceuticals Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Fredun Pharmaceuticals Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |